| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Van Houte Hans is a Chief Financial Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $885K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 3,546 | $24.28 | $86,083.41 | -9.5% | -18.2% | -47.1% | |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,368 | $24.31 | $57,554.24 | -6.0% | -18.7% | -46.9% | |
| Aug 26, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 20,000 | $25.22 | $504,370.00 | -39.2% | -15.1% | -62.9% | |
| Aug 1, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 3,477 | $21.45 | $74,575.91 | -3.3% | +12.1% | -48.6% | |
| Jul 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 2,490 | $20.67 | $51,462.57 | -4.4% | +27.3% | -42.8% | |
| Jun 20, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 20,000 | $20.01 | $400,216.00 | -29.3% | +18.0% | -45.2% | |
| May 2, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 3,499 | $12.83 | $44,878.17 | -4.9% | +71.9% | -11.5% | |
| Apr 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,387 | $12.04 | $16,702.53 | -1.9% | +76.8% | -4.1% | |
| Feb 16, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sell | 6,812 | $10.02 | $68,222.86 | -9.1% | +56.0% | +78.2% | |
| Jan 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 1,671 | $7.99 | $13,351.62 | -2.2% | +56.1% | +145.9% |